Coagulation Profile at Chughtai Lab

Coagulation Profile at Chughtai Lab

A Coagulation Profile, also widely referred to as a coagulation panel, coagulation screen, or coagulation studies, is a comprehensive group of specialized blood tests designed to evaluate the physiological integrity of the body’s hemostatic mechanism. Hemostasis is the complex, highly regulated process that prevents excessive blood loss following vascular injury while maintaining blood in a fluid state within the vascular system. This intricate system relies on a delicate balance between blood vessels, blood platelets, and a cascade of plasma proteins known as coagulation factors. When this balance is disrupted, it can lead to either life-threatening hemorrhages or pathological clot formation (thrombosis). At Chughtai Lab, one of Pakistan’s premier diagnostic institutions, the Coagulation Profile is performed using advanced automated systems to provide clinicians with highly precise measurements of these vital clotting pathways.

The coagulation cascade is traditionally divided into three pathways: the extrinsic, intrinsic, and common pathways. The Coagulation Profile systematically assesses these pathways by measuring specific parameters, including Prothrombin Time (PT), International Normalized Ratio (INR), Activated Partial Thromboplastin Time (aPTT), Thrombin Time (TT), and Fibrinogen levels. By evaluating these components, the test helps identify congenital or acquired deficiencies in clotting factors, monitors the efficacy of anticoagulant medications, and assesses overall liver function, as the liver is the primary site for the synthesis of most coagulation proteins. Whether performed as a routine pre-operative screen or as an urgent diagnostic investigation for unexplained bleeding, the Coagulation Profile at Chughtai Lab serves as an indispensable tool in modern clinical medicine, ensuring patient safety and guiding critical therapeutic decisions.

The clinical importance of this profile cannot be overstated. It is essential for diagnosing inherited bleeding disorders such as Hemophilia A and B, Von Willebrand Disease, and rare factor deficiencies. It is equally critical for identifying acquired coagulopathies resulting from vitamin K deficiency, severe liver disease, disseminated intravascular coagulation (DIC), or the presence of circulating anticoagulants. By choosing Chughtai Lab, patients and healthcare providers benefit from a legacy of diagnostic excellence, highly standardized laboratory protocols, and oversight by qualified consultant pathologists, ensuring that every result is both accurate and clinically actionable.

Clinical Procedure: What to Expect

Patient Preparation

Appropriate patient preparation is essential to ensure the accuracy and reliability of Coagulation Profile results, as several external factors can influence blood clotting times. Patients should adhere to the following guidelines prior to sample collection:

• Medication Disclosure: It is absolutely critical to inform the healthcare provider and the laboratory staff of all medications, over-the-counter drugs, herbal supplements, and vitamins currently being taken. Specifically, blood thinners or anticoagulants such as Warfarin (Coumadin), Heparin, Low Molecular Weight Heparin (LMWH), Aspirin, Clopidogrel, and Direct Oral Anticoagulants (DOACs) like Apixaban or Rivaroxaban must be documented.
• Fasting Requirements: Routine fasting is generally not required for a Coagulation Profile. However, if other tests are being performed on the same blood sample (such as a lipid profile or fasting blood sugar), fasting for 8 to 12 hours may be necessary. Patients should follow their physician’s specific instructions.
• Hydration: Staying well-hydrated by drinking plenty of water is highly recommended, as it makes venipuncture easier and prevents hemoconcentration, which can affect test results.
• Avoid Alcohol and Tobacco: Patients should refrain from consuming alcohol and smoking for at least 24 hours before the test, as these substances can temporarily alter clotting factor levels and platelet function.
• Avoid Strenuous Exercise: Intense physical activity should be avoided immediately before the test, as physical stress can transiently elevate certain coagulation factors, such as Factor VIII, and alter fibrinolytic activity.

During the Procedure

The Coagulation Profile requires a standard venous blood sample, typically collected from a vein in the arm. The procedure is performed by a trained phlebotomist at Chughtai Lab and follows strict clinical protocols to prevent sample contamination or pre-analytical errors:

• Patient Positioning: The patient is asked to sit comfortably in a phlebotomy chair or lie down if they feel lightheaded. The arm is extended and supported on an armrest.
• Site Selection and Cleansing: The phlebotomist identifies a suitable vein, usually in the antecubital fossa (the crease of the elbow). The skin over the selected vein is thoroughly cleansed with an antiseptic solution (typically 70% isopropyl alcohol) and allowed to air dry completely to prevent hemolysis.
• Tourniquet Application: A tourniquet is applied 3 to 4 inches above the puncture site to increase venous pressure and make the vein more visible and palpable. The tourniquet is left in place for less than one minute to avoid hemoconcentration.
• Venipuncture and Sample Collection: A sterile, single-use needle is inserted into the vein. For coagulation studies, blood is drawn into a specific light blue-top tube containing 3.2% buffered sodium citrate. This anticoagulant binds calcium in the blood, preventing clotting within the tube while preserving the coagulation factors for laboratory analysis. The tube must be filled completely to the marked line to ensure the correct 9:1 ratio of blood to anticoagulant, which is critical for accurate results.
• Needle Removal and Hemostasis: Once the sample is collected, the tourniquet is released, the needle is gently withdrawn, and immediate pressure is applied to the puncture site with a sterile gauze pad to stop bleeding. A bandage is then applied.
• Sample Mixing: Immediately after collection, the sodium citrate tube is gently inverted 3 to 4 times to ensure thorough mixing of the blood with the anticoagulant. Vigorous shaking is strictly avoided, as it can cause hemolysis or activate platelets, rendering the sample invalid.
• Safety and Comfort: The entire process takes less than five minutes. Patients may feel a brief, mild pinch as the needle enters the skin. Complications are extremely rare and typically limited to minor bruising at the puncture site.

When is a Coagulation Profile Performed?

Unexplained or Excessive Bleeding

Physicians frequently request a Coagulation Profile when a patient presents with symptoms of unexplained, easy, or prolonged bleeding. This includes frequent and severe nosebleeds (epistaxis), bleeding gums, unusually heavy or prolonged menstrual periods (menorrhagia), extensive bruising (ecchymosis) from minor impacts, or prolonged bleeding from minor cuts and dental procedures. By measuring the time it takes for blood to clot along both the intrinsic and extrinsic pathways, the profile helps clinicians determine whether the bleeding is due to a deficiency in specific clotting factors, platelet dysfunction, or vascular abnormalities, thereby guiding targeted diagnostic investigations.

Recurrent Blood Clots (Thrombosis)

While a Coagulation Profile is commonly associated with bleeding risks, it is equally vital in evaluating patients with a history of inappropriate or recurrent blood clots. Conditions such as Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), or unexplained arterial thromboses require a thorough investigation of the coagulation system. A coagulation panel can identify underlying hypercoagulable states (thrombophilia), such as the presence of lupus anticoagulants or antiphospholipid antibodies, which paradoxically prolong certain in vitro clotting tests like the aPTT while increasing the risk of in vivo clotting. Identifying these conditions is crucial for determining the duration and intensity of long-term anticoagulant therapy.

Pre-Operative Surgical Evaluation

Before undergoing any major surgical procedure, dental surgery, or invasive biopsy, patients are routinely prescribed a Coagulation Profile. This pre-operative screening is essential to assess the patient’s baseline clotting ability and identify any silent or undiagnosed bleeding disorders that could lead to catastrophic, uncontrolled hemorrhage during or after surgery. If abnormal clotting times are detected, the surgical team can take appropriate precautionary measures, such as preparing specific clotting factor concentrates, fresh frozen plasma (FFP), or platelets, or adjusting the surgical approach to minimize bleeding risks.

Monitoring Anticoagulant Therapy

Patients who are prescribed anticoagulant medications (blood thinners) to prevent stroke, treat deep vein thrombosis, or manage artificial heart valves require regular monitoring to ensure their medication dosage is within the safe and effective therapeutic window. For patients on Warfarin (Coumadin), the Prothrombin Time (PT) and International Normalized Ratio (INR) are monitored frequently to prevent under-dosing (which increases clot risk) or over-dosing (which increases severe bleeding risk). Similarly, the Activated Partial Thromboplastin Time (aPTT) is used to monitor patients receiving intravenous unfractionated heparin therapy in hospital settings.

Assessment of Chronic Liver Disease

The liver plays a central role in hemostasis, as it is responsible for synthesizing nearly all coagulation factors (including Factors I, II, V, VII, IX, X, and XI) as well as natural anticoagulants like antithrombin and protein C. In patients with chronic liver diseases such as cirrhosis, hepatitis, or acute liver failure, the liver’s synthetic capacity is severely compromised. A Coagulation Profile, particularly the PT/INR, serves as a highly sensitive indicator of liver function and is a key component of clinical scoring systems (such as the MELD score) used to assess the severity of liver disease and prioritize patients for liver transplantation.

What Does a Coagulation Profile Detect?

A Coagulation Profile at Chughtai Lab is a powerful diagnostic tool that can detect, differentiate, and monitor a wide array of hematological conditions, congenital deficiencies, and acquired disorders. By analyzing the specific patterns of prolongation or deficiency across the different parameters, the profile can detect:

• Hemophilia A: An inherited deficiency of Coagulation Factor VIII, characterized by a prolonged aPTT with a normal PT.
• Hemophilia B: An inherited deficiency of Coagulation Factor IX (Christmas disease), which also presents with an isolated prolonged aPTT.
• Von Willebrand Disease (vWD): The most common hereditary bleeding disorder, which can cause a prolonged aPTT due to reduced levels of Von Willebrand factor, which stabilizes Factor VIII.
• Vitamin K Deficiency: Essential for the synthesis of Factors II, VII, IX, and X; deficiency leads to prolongation of both PT and aPTT, with PT usually affected first.
• Disseminated Intravascular Coagulation (DIC): A life-threatening systemic condition characterized by widespread clotting and subsequent depletion of platelets and clotting factors, resulting in prolonged PT, aPTT, and severely decreased fibrinogen.
• Cirrhosis and Liver Failure: Reduced synthesis of clotting factors leading to a prolonged PT/INR and aPTT.
• Lupus Anticoagulant: An autoantibody associated with antiphospholipid syndrome that prolongs the aPTT in vitro but increases the risk of thrombosis in vivo.
• Heparin Contamination or Therapy: Marked prolongation of the aPTT, and to a lesser extent the PT, due to the inhibitory effect of heparin on thrombin and Factor Xa.
• Warfarin (Coumadin) Effect: Therapeutic or toxic levels of warfarin, which selectively prolongs the PT/INR.
• Factor VII Deficiency: A rare congenital or acquired disorder that causes an isolated prolongation of the PT.
• Factor X, V, or II Deficiencies: Deficiencies in the common pathway factors, which cause prolongation of both PT and aPTT.
• Fibrinogen Deficiency (Afibrinogenemia/Hypofibrinogenemia): Low levels of fibrinogen due to genetic mutations or consumption, leading to prolonged PT, aPTT, and Thrombin Time.
• Dysfibrinogenemia: Structurally abnormal fibrinogen that does not function correctly, prolonging clotting times.
• Factor XI Deficiency (Hemophilia C): An autosomal bleeding disorder that causes a prolonged aPTT, common in certain ethnic populations.
• Factor XII Deficiency: A condition that causes marked prolongation of the aPTT in vitro but does not cause clinical bleeding.
• Direct Oral Anticoagulant (DOAC) Activity: The presence and activity of newer oral anticoagulants like Rivaroxaban, Apixaban, or Dabigatran.
• Severe Sepsis-Induced Coagulopathy: Early stages of coagulation impairment caused by systemic bacterial infections.
• Malabsorption Syndromes: Conditions like Celiac disease or Crohn’s disease that impair Vitamin K absorption, leading to factor deficiencies.
• Acquired Factor Inhibitors: Autoantibodies directed against specific clotting factors (most commonly Factor VIII), causing severe bleeding and prolonged clotting times.
• Thrombocytopenia: Low platelet counts (when evaluated alongside a complete blood count), which compounds bleeding risks identified in the coagulation profile.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is widely recognized for its state-of-the-art laboratory information management systems (LIMS) and highly optimized workflow processes, which ensure rapid turnaround times without compromising diagnostic accuracy. For a routine Coagulation Profile, the standard turnaround time is typically within 4 to 6 hours from the time the blood sample is received at the main testing facility. For urgent pre-operative cases or emergency room patients, STAT testing is available, with results delivered in under 2 hours.

Patients and referring physicians can access reports through multiple convenient digital channels. Once the results are verified by a consultant pathologist, an automated SMS notification containing a direct download link is sent to the patient’s registered mobile number. Reports can also be accessed and downloaded anytime via the official Chughtai Lab website portal or the user-friendly Chughtai Lab Mobile App, available on both iOS and Android platforms. For those who prefer physical copies, reports can be collected from any of the hundreds of Chughtai Lab collection centers located across Pakistan, or delivered directly to the patient’s home through their dedicated home delivery service.

Coagulation Profile Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Prothrombin Time (PT)	11.0 – 13.5 seconds	Prolonged in liver disease, Vitamin K deficiency, Warfarin therapy, or Factor VII deficiency.
International Normalized Ratio (INR)	0.8 – 1.1 (Target 2.0 – 3.0 for therapeutic anticoagulation)	Elevated in Warfarin toxicity, severe liver dysfunction, or active consumption coagulopathy.
Activated Partial Thromboplastin Time (aPTT)	25.0 – 35.0 seconds	Prolonged in Heparin therapy, Hemophilia A/B/C, Von Willebrand disease, or Lupus anticoagulant.
Fibrinogen Level	200 – 400 mg/dL	Decreased in DIC, severe liver disease, or hereditary afibrinogenemia; Elevated in acute inflammation.
Thrombin Time (TT)	12.0 – 19.0 seconds	Prolonged in Heparin contamination, hypofibrinogenemia, or presence of fibrin degradation products (FDPs).
Platelet Count	150,000 – 450,000 /µL	Thrombocytopenia (increased bleeding risk) or Thrombocytosis (increased clotting risk).

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Coagulation Profile?

• Accredited Quality Standards: Chughtai Lab operates in strict compliance with international quality standards, utilizing College of American Pathologists (CAP) guidelines and ISO 15189 certifications to ensure world-class diagnostic accuracy.
• Experienced Pathologists: All hematology and coagulation profiles are supervised, reviewed, and signed off by highly qualified Consultant Pathologists and Hematologists.
• Advanced Automation: The laboratory is equipped with state-of-the-art, fully automated coagulation analyzers that minimize human error and deliver highly reproducible results.
• Extensive Network: With over 300 collection centers across Pakistan, patients can easily access testing services in almost every major city, including Lahore, Karachi, and Islamabad.
• Convenient Home Sampling: Chughtai Lab offers a highly professional home sample collection service, allowing patients to have their blood drawn in the comfort of their homes by trained phlebotomists.
• Rapid Turnaround Time: Highly efficient processing systems ensure that routine and urgent coagulation reports are delivered promptly to facilitate timely medical interventions.
• Seamless Digital Access: Patients can view, download, and archive their reports online via the Chughtai Lab website or mobile application, ensuring easy sharing with healthcare providers.
• Patient-Centric Care: Chughtai Lab is committed to providing a compassionate, comfortable, and professional environment for all patients, ensuring a hassle-free diagnostic experience.